Merck & Co., Inc. ($MRK)
Filing Information
| Accession Number | 0000310158-26-000036 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
45,261
Total Value
$2,637,299.63
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Executive VP & President, MRL | Common Stock | โ | Feb 4, 2026 | Exercise/Conversion | 15,087 | $56.04 | $845,475.48 | 117,357 | Direct | โ | View Details | |
Executive VP & President, MRL | Common Stock | โ | Feb 4, 2026 | Sale | 15,087 | $118.77 | $1,791,824.15 | 102,270 | Direct | โ | View Details | |
Executive VP & President, MRL | Stock Option (Right to Buy) | Derivative | Feb 4, 2026 | Exercise/Conversion | 15,087 | $0.00 | $0.00 | 0 | Direct | โ | View Details |